Search research articles
Contact Us
Filters
Showing results (441-450 of 447) with videos related to
Page
of 45
Sort By:
You have reached the last page of results.
This site can display upto 447 results.
JCI Insight
|
May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Cell Reports
|
January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
Heather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
The Journal of Clinical Investigation
|
September 9, 2025
A multiomics recovery factor predicts long COVID in the IMPACC study
Gisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
Nature Microbiology
|
March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
Kexin Wang, Yutong Nie, Cole Maguire, et al.
Nature Communications
|
January 3, 2024
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Al Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Science (New York, N.Y.)
|
September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
Kathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Page
of 45
Search research articles
Search
Showing results (441-450 of 447) with videos related to
Sort By:
Page
of 45
You have reached the last page of results.
This site can display upto 447 results.
JCI Insight
|
May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Cell Reports
|
January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
Heather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
The Journal of Clinical Investigation
|
September 9, 2025
A multiomics recovery factor predicts long COVID in the IMPACC study
Gisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
Nature Microbiology
|
March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
Kexin Wang, Yutong Nie, Cole Maguire, et al.
Nature Communications
|
January 3, 2024
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Al Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Science (New York, N.Y.)
|
September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
Kathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Page
of 45